EdgarLookup

ELITE PHARMACEUTICALS INC /NV/ — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
BEHL CHARAN Purchase 15,000 $0.80 $12,000 515,000 Apr 2, 2008
BEHL CHARAN Purchase 5,000 $0.90 $4,500 500,000 Mar 28, 2008
BEHL CHARAN Purchase 5,000 $0.96 $4,800 495,000 Mar 26, 2008
BEHL CHARAN Purchase 4,061 $1.00 $4,061 489,061 Feb 8, 2008
BEHL CHARAN Purchase 5,000 $0.77 $3,850 456,450 Feb 5, 2008
BEHL CHARAN Purchase 10,000 $0.93 $9,300 445,000 Jan 30, 2008
BEHL CHARAN Purchase 5,000 $1.16 $5,800 421,000 Jan 28, 2008
BERK BERNARD Chairman, CEO and President Purchase 2,500 $2.05 $5,125 194,800 Dec 31, 2007
BERK BERNARD CEO and Chairman Purchase 5,000 $2.02 $10,100 184,800 Nov 20, 2007
Dash Barry H Purchase 4,600 $2.40 $11,040 4,600 Jul 3, 2006
NEUGEBOREN EDWARD Tax Withholding 10,163 $1.54 $15,651 30,488 Dec 31, 2005